D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two...
WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the "A List" for leadership in corporate...
Aeronero Receives Frost & Sullivan's 2025 Global Transformational Innovation Leadership Recognition for Pioneering Advancements in Atmospheric Water Generation
Recognized for redefining water security through breakthrough hybrid atmospheric water generation technology and sustainable innovation SAN ANTONIO, Jan. 13, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Aeronero has been...
Frost & Sullivan: Paragraf Receives the 2025 European Graphene-Based Electronics Manufacturing Technology Innovation Leadership Recognition for Excellence in Semiconductor Innovation
The company's direct, contaminant-free graphene deposition method is a manufacturing breakthrough SAN ANTONIO, Jan. 7, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Paragraf has earned the 2025 European Technology Innovation...
BlueSG Receives Frost & Sullivan's 2025 Asia-Pacific Customer Value Leadership Recognition for Excellence in Car-sharing Industry
Frost & Sullivan applauds BlueSG's customer-centric approach, digital transformation, and operational agility in redefining urban mobility through its innovative car-sharing model. SAN ANTONIO, Jan. 6, 2026 /PRNewswire/ -- Frost & Sullivan...
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an internally...
GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared the...
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D on core technologies, including expansion of indications for the Grabody platform SEOUL, South...
Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study
SHANGHAI, Dec. 24, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance from the U.S. Food and Drug Administration (FDA) for its...
Cambridge Mobile Telematics Receives Frost & Sullivan's 2025 Global Telematics Insurance and Connected Claims Market Leadership Recognition for Excellence in Mobility Ecosystem Innovation
CMT is honored for advancing crash technology and shaping the future of mobility ecosystems through industry-leading telematics, AI-driven insights, and connected claims innovation. SAN ANTONIO, Dec. 19, 2025 /PRNewswire/ -- Frost & Sullivan is...